Flourish Research Acquires Diablo Clinical Research

Flourish Research (NMS Capital-backed) Acquires Valley Clinical Trials

September 15, 2023

Healthcare Services

NMS Capital–backed Flourish Research has acquired Valley Clinical Trials, a three-site clinical research organization in Los Angeles County focused on cardiology, metabolic and related therapeutic areas. The deal — Flourish’s ninth acquisition since 2021 — expands the platform’s West Coast footprint; terms were not disclosed and Valley’s founder and management will remain in their roles.

Genstar Capital Acquires Majority Stake in Flourish Research

September 18, 2024

Healthcare Services

Genstar Capital has made a strategic majority investment in Flourish Research, a multi-site clinical trial organization headquartered in Apex, North Carolina. The transaction represents an exit for NMS Capital, which built Flourish into a 24-site network with ~150 investigators and scaled the business through infrastructure investments and acquisitions.

Flourish Research Invests in Valkyrie Clinical Trials

October 6, 2025

Healthcare Services

Flourish Research, a Genstar Capital-backed multi-site clinical trial organization, has made a strategic investment in Valkyrie Clinical Trials to establish a meaningful presence in oncology. Valkyrie, founded by Dr. David Berz and operating three sites in Los Angeles, will leverage Flourish's national network and infrastructure to accelerate oncology trial access and patient recruitment.

NMS-backed Flourish Research Recapitalizes Great Lakes Clinical Trials and Clinical Site Partners

January 12, 2022

Healthcare Services

NMS Capital portfolio company Flourish Research completed recapitalizations of Great Lakes Clinical Trials and Clinical Site Partners, expanding its multi-site clinical trial network across Illinois, Florida and Texas. The deals (terms undisclosed) add site capacity and management teams to Flourish Research as the platform pursues network consolidation, improved operational efficiencies and accelerated growth.

Flourish Research (NMS Capital) Recapitalizes Keystone Clinical Studies

October 6, 2022

Healthcare Services

Flourish Research, a portfolio company of NMS Capital, partnered with Keystone Clinical Studies' management in a recapitalization transaction. Keystone, a Plymouth Meeting, Pennsylvania-based clinical research site focused on Alzheimer’s disease and CNS conditions, will continue to be led by founder Dr. Cherian Verghese as part of the Flourish platform to expand CNS capabilities and enter the Philadelphia market.

Flourish Research Acquires Center for Advanced Research & Education (CARE)

May 7, 2025

Healthcare Services

Flourish Research, a multi-site clinical trial organization headquartered in Apex, North Carolina, acquired the Center for Advanced Research & Education (CARE), a Gainesville, Georgia-based clinical research facility. The deal expands Flourish's geographic footprint into the Southeast, strengthens its oncology capabilities, and deepens relationships with pharmaceutical sponsor clients.